Our Company
Our Mission & Commitment
Key Facts
Leadership
Governance
History
Compliance & Ethics
Diversity & Inclusion
Our Websites
Achievements
Business Information
R&D
R&D Strategy
In the Pipeline
Investigational Compound News
Disease Areas of Focus
Our R&D
Our Science
R&D Highlights
Major R&D Facilities
Clinical Trials
Products
Patient Assistance Programs
Prescribing Information
R&D
Clinical Trials
Counterfeit Drugs
Product Information Inquiries
News
Press Releases
Publications
Media Library
Key Facts
Leadership
Financial Reporting
Features
Achievements
Media Contacts
Subscribe to e-mail alerts
Investors
Key Facts
Stock Information
SEC Filings
Financial Reporting
Events & Presentations
Shareholder Services
Investor Contacts
Partnering
Why Partner With Us?
Areas of Interest
Our Process
Our Partners
Partnering News
Partnering Contact
Responsibility
Bristol-Myers Squibb Foundation
Sustainability
Patient Assistance Programs
Building Our Communities
Grants & Giving
Position on Key Issues
Clinical Trials
Combating Counterfeit Drugs
Achievements
Careers
Job Opportunities
Our Culture
Diversity & Inclusion
Developing Our People
University Recruitment
Achievements
Benefits
Manage My Profile
Apply Now
SITE INDEX
|
CONTACT US
|
TERMS
|
PRIVACY
August 2010
Statement on BMS
HIV/AIDS Access Programs
for Least Developed Countries
Ensuring Access to HIV/AIDS
Medicine in the U.S.
Statement on
VIDEX® (didanosine) Supply
July 12, 2010
COUMADIN® (warfarin sodium)
1 mg Blister Packs
Recall Information
Health Care Professionals
Access
medical information and resources
Clinical Trials
Clinical trials
sponsored by Bristol-Myers Squibb
Bristol-Myers Squibb
clinical trials for cancer
Need Help Paying for Your Bristol-Myers Squibb Medicines?
Learn about our
assistance programs
.
Our Environmental
Stewardship
Bristol-Myers Squibb Foundation:
Supporting Innovations in Mental Health
Project seeks to lower recidivism in people with
serious mental illness
.
LATEST NEWS
August 25, 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
August 18, 2010
Ipilimumab Receives FDA Priority Review Designation for Adult Patients with Previously Treated Advanced Melanoma
August 14, 2010
Data on Investigational Drug Belatacept in Kidney Transplant Recipients to Be Presented at 23rd International Congress of The Transplantation Society
August 11, 2010
Bristol-Myers Squibb and ADAP Crisis Task Force Announce Enhanced, Multi-year Support for AIDS Drug Assistance Programs (ADAPs) in the United States
Get RSS News Alerts
Follow us on twitter.com/bmsnews